Navy Secretary out, HOPSS and OMNIBUS IV confirmed as small-business and 8(a) plays, and DHA is executing contract options two weeks before most agencies wake up to EOFY. The acquisition environment is actively repricing incumbency this week.
Three things happened this week that matter more than the headlines suggested.
Navy Secretary John Phelan was fired. HHS and DHA confirmed two large vehicles are moving to restricted small-business competition. And Defense Health Agency obligations kicked off two weeks before most agencies even start thinking about end-of-fiscal-year execution. These are not three separate stories. They are one story about how quickly the federal acquisition posture is repricing who can win what.
Pete Hegseth, who now operates as Secretary of War after the DoD rebrand, called Phelan on Wednesday April 22 and asked him to resign. Phelan had spent the day on Capitol Hill walking lawmakers through the Navy's budget request. Pentagon spokesperson Sean Parnell posted the departure announcement on social media within hours, per Heather Cox Richardson's reporting and the Wall Street Journal account cited by multiple outlets. The New York Times and NBC News both tied the firing to Hegseth's frustration with the pace of Trump's "Golden Fleet" shipbuilding plans. Undersecretary Hung Cao is acting Secretary.
What this means for contractors: the Pentagon is willing to remove senior civilian leadership over execution speed. If your contract touches shipbuilding, naval R&D, or any program on the Hegseth priority list, assume the ground is moving. Incumbent relationships built under Phelan are not a moat. Whatever was slow under him gets faster or gets reshaped, and that reshape happens through acquisition authority pushed down to combatant commands or up to OSD acquisition leadership.
This is not the first Hegseth firing this year. Army Chief of Staff Gen. Randy George was removed on April 2 and replaced by Vice Chief Gen. Christopher LaNeve as acting chief, per Politico. The Democracy Now wire summarizing the WSJ reporting lists a string of additional senior Pentagon departures since January, including the Chairman of the Joint Chiefs and the Chief of Naval Operations. Pattern is clear. Speed of execution is the metric. Anything that slows it gets cut.
Two of the largest federal health vehicles confirmed this week that their next cycles are restricted competitions, not open ones.
HHS's HOPSS vehicle, the follow-on to NIH's current SOAR contract, carries a $3.6 billion ceiling and expands from NIH-only coverage to all 13 HHS operating divisions and 10 regional offices. The capture analysis published April 20 confirms this is going forward as a small business set-aside under NAICS 541690, with a $19 million size standard. None of the five SOAR incumbents qualify as small under that code. The RFP is expected Q2 FY27, award Q2 FY28, with incumbents bridged through 2027.
On the DoD side, DHA's OMNIBUS IV on-ramp has been confirmed as an 8(a)-only set-aside, with solicitation now expected late May 2026 per the April 13 update and the DHACA pre-solicitation on HigherGov. Cumulative ceiling is $10 billion. The date slipped because the government needs to align the RFP with the FAR Overhaul guidance that DoD started adopting February 1.
Read these two decisions together. The largest new professional services vehicles at HHS and DHA are now explicitly not for graduated small businesses or non-8(a) firms. If you are not 8(a) certified or not small under the relevant NAICS codes, your path is teaming as a sub, not leading as a prime. If you are 8(a) or small, the structural advantage is real, and the capture window for HOPSS is open right now because the RFP is more than a year out.
Everyone talks about the September obligation rush. Defense Health Agency is not waiting.
On April 15, DHA modified its dental coverage contract with United Concordia for $132,005,812 to exercise Option Period Five, covering active-duty care from May 2026 through April 2027, per the Department of War contracts post. A day later, on April 16, QBase LLC in Reston picked up a $16,355,750 bridge for MHS network sustainment across military treatment facilities worldwide, six-month base plus six-month option.
These are O&M dollars moving now, not in August. The signal: DHA is executing ahead of the pace and expects its vehicles to be fed before September. Small businesses holding task order positions on MHS IT, clinical support, and medical logistics vehicles should push for work orders now. The calendar they're operating on is April through July, not June through September.
On the HHS side, CMS Administrator Mehmet Oz told state governors at a Politico health care policy forum on April 22 that every state has 30 days to submit a plan for revalidating Medicaid providers, per HealthExec. All 50 states. Identity checks, license verification, fraud screening. This is an immediate, unbudgeted demand signal for consulting, data analytics, and compliance review services, most of it running through NAICS 541611. Firms with existing state Medicaid integrity contracts have a running start. Firms without them should be talking to their state MMIS prime this week.
For the research-focused readers: CDMRP's FY26 cycle is actively pushing pre-announcements to Grants.gov ahead of Notices of Funding Opportunities. The Neurofibromatosis Research Program pre-announcement dropped April 22, with mechanisms ranging from $160,000 Exploration-Hypothesis Development Awards up to $3.2 million Synergistic Idea Awards and $2.4 million Academy Leadership Awards, per cdmrp.health.mil. Rare Cancers (April 8) and Kidney Cancer (April 15) pre-announcements are also live. Full NOFOs are pending Executive Order 14332 approval before posting.
The FY26 total CDMRP appropriation sits at $1.27 billion across 34 programs, restored from the FY25 continuing resolution cut. If you run or support research, your team should be writing letters of intent right now.
Defense Health Agency itself continues reinforcing its "combat support agency" identity under Vice Adm. Darin K. Via, with the Operational Medical Systems Force Health Protection division at Fort Detrick highlighted in an April 22 DHA feature on how Col. Chuck Bane's team uses Emergency Use Authorizations and Investigational New Drug protocols to push medical countermeasures forward. For small businesses with therapeutic, diagnostic, or preventive portfolios, FHP is the door. They are actively looking for industry partners who can move at the speed of the Joint Force.
Three moves for next week.
First, if you are capture-eligible for HOPSS or OMNIBUS IV on-ramp, finalize teaming decisions now. Both windows are open. OMNIBUS IV will be a tight turn: late May solicitation means June proposals.
Second, if you hold task order positions on MHS IT, clinical, or logistics vehicles, contact your contracting officer this week to push work orders. The obligation window is open and DHA is moving.
Third, if you have state Medicaid relationships, translate the 30-day Oz directive into a proposal to your state health agency today. Thirty days is not a lot of time and every state just got the same letter.
The acquisition environment is not stable. It is getting faster and more restrictive at the same time. Small businesses that can move on 72-hour decision cycles are the ones who will collect this quarter.
Let's roll.
— Mary
Mission Meets Tech